Cargando…

NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks

BACKGROUND: Genetic networks control cellular functions. Aberrations in normal cellular function are caused by mutations in genes that disrupt the fine tuning of genetic networks and cause disease or disorder. However, the large number of signalling molecules, genes and proteins that constitute such...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasaikar, Suhas V, Padhi, Aditya K, Jayaram, Bhyravabhotla, Gomes, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570275/
https://www.ncbi.nlm.nih.gov/pubmed/23286825
http://dx.doi.org/10.1186/1471-2202-14-3
_version_ 1782259036005072896
author Vasaikar, Suhas V
Padhi, Aditya K
Jayaram, Bhyravabhotla
Gomes, James
author_facet Vasaikar, Suhas V
Padhi, Aditya K
Jayaram, Bhyravabhotla
Gomes, James
author_sort Vasaikar, Suhas V
collection PubMed
description BACKGROUND: Genetic networks control cellular functions. Aberrations in normal cellular function are caused by mutations in genes that disrupt the fine tuning of genetic networks and cause disease or disorder. However, the large number of signalling molecules, genes and proteins that constitute such networks, and the consequent complexity of interactions, has restrained progress in research elucidating disease mechanisms. Hence, carrying out a systematic analysis of how diseases alter the character of these networks is important. We illustrate this through our work on neurodegenerative disease networks. We created a database, NeuroDNet, which brings together relevant information about signalling molecules, genes and proteins, and their interactions, for constructing neurodegenerative disease networks. DESCRIPTION: NeuroDNet is a database with interactive tools that enables the creation of interaction networks for twelve neurodegenerative diseases under one portal for interrogation and analyses. It is the first of its kind, which enables the construction and analysis of neurodegenerative diseases through protein interaction networks, regulatory networks and Boolean networks. The database has a three-tier architecture - foundation, function and interface. The foundation tier contains the human genome data with 23857 protein-coding genes linked to more than 300 genes reported in clinical studies of neurodegenerative diseases. The database architecture was designed to retrieve neurodegenerative disease information seamlessly through the interface tier using specific functional information. Features of this database enable users to extract, analyze and display information related to a disease in many different ways. CONCLUSIONS: The application of NeuroDNet was illustrated using three case studies. Through these case studies, the construction and analyses of a PPI network for angiogenin protein in amyotrophic lateral sclerosis, a signal-gene-protein interaction network for presenilin protein in Alzheimer's disease and a Boolean network for a mammalian cell cycle was demonstrated. NeuroDNet is accessible at http://bioschool.iitd.ac.in/NeuroDNet/.
format Online
Article
Text
id pubmed-3570275
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35702752013-02-15 NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks Vasaikar, Suhas V Padhi, Aditya K Jayaram, Bhyravabhotla Gomes, James BMC Neurosci Database BACKGROUND: Genetic networks control cellular functions. Aberrations in normal cellular function are caused by mutations in genes that disrupt the fine tuning of genetic networks and cause disease or disorder. However, the large number of signalling molecules, genes and proteins that constitute such networks, and the consequent complexity of interactions, has restrained progress in research elucidating disease mechanisms. Hence, carrying out a systematic analysis of how diseases alter the character of these networks is important. We illustrate this through our work on neurodegenerative disease networks. We created a database, NeuroDNet, which brings together relevant information about signalling molecules, genes and proteins, and their interactions, for constructing neurodegenerative disease networks. DESCRIPTION: NeuroDNet is a database with interactive tools that enables the creation of interaction networks for twelve neurodegenerative diseases under one portal for interrogation and analyses. It is the first of its kind, which enables the construction and analysis of neurodegenerative diseases through protein interaction networks, regulatory networks and Boolean networks. The database has a three-tier architecture - foundation, function and interface. The foundation tier contains the human genome data with 23857 protein-coding genes linked to more than 300 genes reported in clinical studies of neurodegenerative diseases. The database architecture was designed to retrieve neurodegenerative disease information seamlessly through the interface tier using specific functional information. Features of this database enable users to extract, analyze and display information related to a disease in many different ways. CONCLUSIONS: The application of NeuroDNet was illustrated using three case studies. Through these case studies, the construction and analyses of a PPI network for angiogenin protein in amyotrophic lateral sclerosis, a signal-gene-protein interaction network for presenilin protein in Alzheimer's disease and a Boolean network for a mammalian cell cycle was demonstrated. NeuroDNet is accessible at http://bioschool.iitd.ac.in/NeuroDNet/. BioMed Central 2013-01-03 /pmc/articles/PMC3570275/ /pubmed/23286825 http://dx.doi.org/10.1186/1471-2202-14-3 Text en Copyright ©2013 Vasaikar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Database
Vasaikar, Suhas V
Padhi, Aditya K
Jayaram, Bhyravabhotla
Gomes, James
NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title_full NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title_fullStr NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title_full_unstemmed NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title_short NeuroDNet - an open source platform for constructing and analyzing neurodegenerative disease networks
title_sort neurodnet - an open source platform for constructing and analyzing neurodegenerative disease networks
topic Database
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570275/
https://www.ncbi.nlm.nih.gov/pubmed/23286825
http://dx.doi.org/10.1186/1471-2202-14-3
work_keys_str_mv AT vasaikarsuhasv neurodnetanopensourceplatformforconstructingandanalyzingneurodegenerativediseasenetworks
AT padhiadityak neurodnetanopensourceplatformforconstructingandanalyzingneurodegenerativediseasenetworks
AT jayarambhyravabhotla neurodnetanopensourceplatformforconstructingandanalyzingneurodegenerativediseasenetworks
AT gomesjames neurodnetanopensourceplatformforconstructingandanalyzingneurodegenerativediseasenetworks